can semaglutide cause stroke Semaglutide, other obesity drugs show potential to treat nondiabetic GLP-1 receptor agonists in stroke

For doses under 20 units, the lines can feel cramped and difficult to distinguish

Additionally, if patients are monitoring only body weight without considering other metabolic improvements (such as reduced fasting glucose, decreased appetite, or improved postprandial glucose excursions), they may underestimate the medication's effects

Semaglutide GLP-1 effectively suppresses hunger, increases feelings of fullness, and slows the process of gastric emptying, making it a useful tool for individuals who want to reduce their calorie intake and manage their weight

Symptoms include dizziness, sweating, confusion, and, in severe cases, loss of consciousness

Acknowledgments We thank Chih-Shung Wongs research assistants, Ching-Pai Wang and Tsou-Mei Liu, for performing animal drug administration and organ dissection for the studies